ChemicalBook > CAS DataBase List > DCZ0415
DCZ0415
- Product Name
- DCZ0415
- CAS No.
- 2242470-43-3
- Chemical Name
- DCZ0415
- Synonyms
- DCZ0415;DCZ0415, 10 mM in DMSO;2-(4-(Pyridin-4-ylmethyl)phenyl)-4,4a,5,5a,6,6a-hexahydro-4,6-ethenocyclopropa[f]isoindole-1,3(2H,3aH)-dione;4,6-Ethenocycloprop[f]isoindole-1,3(2H,3aH)-dione, 4,4a,5,5a,6,6a-hexahydro-2-[4-(4-pyridinylmethyl)phenyl]-;DCZ0415,DCZ 0415,Apoptosis,inhibit,nonhomologous,Nuclear factor-κB,TRIP13,Inhibitor,joining,DCZ-0415,end,drug-resistant,myeloma,repair,anti-myeloma,Nuclear factor-kappaB,NF-κB
- CBNumber
- CB48029461
- Molecular Formula
- C23H20N2O2
- Formula Weight
- 356.42
- MOL File
- 2242470-43-3.mol
More
Less
DCZ0415 Property
- Boiling point:
- 624.2±55.0 °C(Predicted)
- Density
- 1.319±0.06 g/cm3(Predicted)
- solubility
- DMSO:62.5(Max Conc. mg/mL);175.35(Max Conc. mM)
- form
- Solid
- pka
- 5.80±0.10(Predicted)
- color
- Off-white to yellow
More
Less
N-Bromosuccinimide Price
Axon Medchem
- Product number
- Axon3216
- Product name
- DCZ0415
- Purity
- 99%
- Packaging
- 5mg
- Price
- $93.5
- Updated
- 2021/12/16
ChemScene
- Product number
- CS-0109396
- Product name
- DCZ0415
- Purity
- 99.96%
- Packaging
- 5mg
- Price
- $145
- Updated
- 2021/12/16
Axon Medchem
- Product number
- Axon3216
- Product name
- DCZ0415
- Purity
- 99%
- Packaging
- 2x5mg
- Price
- $154
- Updated
- 2021/12/16
ChemScene
- Product number
- CS-0109396
- Product name
- DCZ0415
- Purity
- 99.96%
- Packaging
- 10mg
- Price
- $250
- Updated
- 2021/12/16
ChemScene
- Product number
- CS-0109396
- Product name
- DCZ0415
- Purity
- 99.96%
- Packaging
- 25mg
- Price
- $530
- Updated
- 2021/12/16
More
Less
DCZ0415 Chemical Properties,Usage,Production
Description
DCZ0415 is a novel inhibitor of TRIP13, suppressing multiple myeloma progression.
Uses
DCZ0415, a potent TRIP13 inhibitor, impairs nonhomologous end joining repair and inhibits NF-κB activity. DCZ0415 induces anti-myeloma activity in vitro, in vivo, and in primary cells derived from drug-resistant myeloma patients[1].
in vivo
DCZ0415 (ip; 50 mg/kg/day for 14 days) significantly reduces the growth of MM cells-induced tumors in immune-deficient mice[1].
| Animal Model: | Nude mice (6-weeks-old) with H929 775 cells[1] |
| Dosage: | 50 mg/kg |
| Administration: | Intraperitoneal injection; every day for 14 days |
| Result: | Significantly reduced the growth of MM cells-induced tumors. |
target
DCZ0415, a potent TRIP13 inhibitor, impairs nonhomologous end joining repair and inhibits NF-κB activity.
IC 50
NF-κB
References
[1] Wang Y, et al. A Small Molecule Inhibitor Targeting TRIP13 suppresses multiple myeloma progression. Cancer Res. 2019 Nov 15. pii: canres.3987.2018. DOI:10.1158/0008-5472.CAN-18-3987
DCZ0415 Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
DCZ0415 Suppliers
- Tel
- 13816613772
- Fax
- QQ: 12922499
- huahero21@sina.com
- Country
- China
- ProdList
- 2495
- Advantage
- 55
- Tel
- 021-65675885 18964387627
- Fax
- 021-65675885
- info@efebio.com
- Country
- China
- ProdList
- 9803
- Advantage
- 58
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32470
- Advantage
- 58
- Tel
- +1-708-310-1919 +1-13798911105
- Fax
- 708-557-7486
- sales@invivochem.cn
- Country
- United States
- ProdList
- 6391
- Advantage
- 58
- Tel
- 18818260767
- Fax
- QQ 3610331285
- sales@chemegen.com
- Country
- China
- ProdList
- 11218
- Advantage
- 58
- Tel
- 15869524721
- 3525679403@qq.com
- Country
- China
- ProdList
- 4899
- Advantage
- 58
- Tel
- 13348960310
- 3003867561@qq.com
- Country
- China
- ProdList
- 10503
- Advantage
- 58
- Tel
- 400-1647117 13681763483
- product02@bidepharm.com
- Country
- China
- ProdList
- 59936
- Advantage
- 58